Daily Oral Emtricitabine/Tenofovir Preexposure Prophylaxis and Herpes Simplex Virus Type 2 among Men Who Have Sex with Men

• Julia L. Marcus,

  Affiliations Gladstone Institute of Virology and Immunology, San Francisco, California, United States or America, University of California, Berkeley, California, United States of America

  ⨯
• David V. Glidden,

  Affiliation University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Vanessa McMahan,

  Affiliation Gladstone Institute of Virology and Immunology, San Francisco, California, United States or America

  ⨯
• Javier R. Lama,

  Affiliation Asociación Civil Impacta Salud y Educación, Lima, Peru

  ⨯
• Kenneth H. Mayer,

  Affiliations Fenway Institute, Fenway Health, Boston, Massachusetts, United States of America, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America

  ⨯
• Albert Y. Liu,

  Affiliation Bridge HIV, San Francisco Department of Public Health, San Francisco, California, United States of America

  ⨯
• Orlando Montoya-Herrera,

  Affiliation Fundación Ecuatoriana Equidad, Guayaquil, Guayas, Ecuador

  ⨯
• Martin Casapia,

  Affiliation Asociación Civil Selva Amazónica, Iquitos, Peru

  ⨯
• Brenda Hoagland,

  Affiliation Instituto de Pesquisa Clínica Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil

  ⨯
• Robert M. Grant

  * E-mail: robert.grant@ucsf.edu

  Affiliations Gladstone Institute of Virology and Immunology, San Francisco, California, United States or America, University of California San Francisco, San Francisco, California, United States of America

  ⨯